Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Glaukos Corp (NY: GKOS ) 120.73 +2.02 (+1.70%) Official Closing Price Updated: 7:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Glaukos Corp < Previous 1 2 3 4 5 6 7 Next > FDA Approves Glaukos' Eye Implant To Treat Eye Pressure In Glaucoma Patients December 14, 2023 The FDA approved Glaukos Corporation's (NYSE: GKOS) marketing application for a single administration per eye of iDose TR (travoprost intracameral implant) 75 mcg, a prostaglandin analog indicated for... Via Benzinga Exposures Product Safety Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant) December 14, 2023 From Glaukos Corporation Via Business Wire Analyst Ratings for Glaukos November 28, 2023 Via Benzinga 4 Analysts Have This to Say About Glaukos November 08, 2023 Via Benzinga Glaukos Announces Participation in Stifel Healthcare Conference November 07, 2023 From Glaukos Corporation Via Business Wire 8 Analysts Have This to Say About Glaukos September 26, 2023 Via Benzinga Glaukos's Earnings Outlook August 01, 2023 Via Benzinga Analyst Ratings for Glaukos July 31, 2023 Via Benzinga Where Glaukos Stands With Analysts July 14, 2023 Via Benzinga Glaukos Announces Third Quarter 2023 Financial Results November 01, 2023 From Glaukos Corporation Via Business Wire Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Academy of Ophthalmology Annual Meeting October 31, 2023 From Glaukos Corporation Via Business Wire Glaukos to Release Third Quarter 2023 Financial Results after Market Close on November 1, 2023 October 11, 2023 From Glaukos Corporation Via Business Wire Glaukos Announces Participation in Wells Fargo Healthcare Conference August 23, 2023 From Glaukos Corporation Via Business Wire Stifel Maintains Buy Rating for Glaukos: Here's What You Need To Know June 26, 2023 Via Benzinga 8 Analysts Have This to Say About Glaukos June 26, 2023 Via Benzinga Analyst Expectations for Glaukos's Future June 05, 2023 Via Benzinga Glaukos Announces Second Quarter 2023 Financial Results August 02, 2023 From Glaukos Corporation Via Business Wire Glaukos Poised To Surpass Expectations And Raise Outlook In Q2 FY23, Fueled By iStent And iAccess Launches: Analyst July 19, 2023 Needham expects Glaukos Corp (NYSE: GKOS) to surpass expectations and raise outlook in Q2 FY23, fueled by rebounding iStent inject volumes post-2022 reimbursement-driven declines. An additional upside... Via Benzinga Glaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc. July 17, 2023 From Glaukos Corporation Via Business Wire These 2 Soaring Stocks Finished the Week Strong July 14, 2023 Wall Street coasted into the close on Friday but still had a good week. Via The Motley Fool Glaukos: Q1 Earnings Insights May 03, 2023 Via Benzinga UnitedHealth, Elanco Animal Health And Other Big Stocks Moving Higher On Friday July 14, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session. Via Benzinga Glaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023 July 12, 2023 From Glaukos Corporation Via Business Wire Glaukos Poised for $1B in Sales by 2030: Piper Sandler Predicts With Stock Upgrade June 07, 2023 Piper Sandler has upgraded Glaukos Corporation (NYSE: GKOS) to Overweight from a Neutral ra Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023 June 07, 2023 Via Benzinga Glaukos Achieves Pipeline Milestone with Enrollment Completion in Phase 3 Confirmatory Trial for Epioxa (Epi-on) June 05, 2023 From Glaukos Corporation Via Business Wire Glaukos Announces Participation in the William Blair Growth Stock Conference May 24, 2023 From Glaukos Corporation Via Business Wire Tyson Foods, PayPal And 3 Stocks To Watch Heading Into Monday May 08, 2023 With US stock futures trading slightly lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: Via Benzinga Glaukos Announces FDA Acceptance of NDA Submission for iDose TR May 05, 2023 From Glaukos Corporation Via Business Wire Glaukos Announces First Quarter 2023 Financial Results May 03, 2023 From Glaukos Corporation Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.